Patients, N | 287 |
Age, mean | 64,7 |
Male gender, N (%) | 204 (71.1) |
Smoking History, N (%) | 126 (43.9)a |
COPD, N (%) | 81 (28.2) |
Cardiovascular Disease, N (%) | 148 (51.6) |
Cancer History, N (%) | 42 (14.6)b |
Lung Cancer History, N (%) | 11 (3.8) |
Instersticial Lung Disease, N (%) | 4 (1.4) |
Tumor Location, N, (%) | |
Right Superior Lobe Left Superior Lobe Right Inferior Lobe Left Inferior Lobe Middle Lobe Lymph Node Right Central Left Central Trachea Bilateral | 86 (30) 76 (26.5) 47 (16.4) 38 (13.2) 11 (3.8) 9 (3.1) 10 (3.5) 3 (1) 2 (0.7) 5 (1.7) |
Total Lymph Nodes punctured, N (mean) | 849 (2.95) |
Number of Lymph Nodes punctured per EBUS, N (%) | |
1 2 3 4 5 6 | 30 (10.5) 56 (19.5) 115 (40.1) 70 (24.4) 14 (4.9) 2 (0.7) |
EBUS with ROSE, N (%) | 130 (45.3) |
Additional Biopsy, N (%) | |
Not performed or not diagnostic Endobronchial Biopsie Transbronchial Biopsie | 153 (53.3) 56 (19.5) 78 (27.2) |
Major Surgical Procedure, N (%) | |
Right Superior Lobectomy Left Superior Lobectomy Right Inferior Lobectomy Left Inferior Lobectomy Bilobectomy Right Pneumectomy Left Pneumectomy Segmentectomy or wedge resection Mediastinoscopy | 71 (24.7) 51 (17.8) 23 (8.0) 23 (8.0) 12 (4.2) 27 (9.4) 22 (7.7) 48 (16.7) 4 (1.4) |
NSCLC after surgical exploration, N (%) | 238 (82.9 %) |
Final Tumor Staging, Nc IA, N (%) IB, N (%) IIA, N (%) IIB, N (%) IIIA, N (%) IIIB, N (%) IV, N (%) | 242 29 (12.0) 39 (16.1) 46 (19.0) 43 (17.8) 66 (27.3) 12 (5.0) 7 (2.9) |